CEACAM5 and neoplasm: The ROC curve analysis of potential serum biomarker and other tumor marker (CEA and CYFRA21-1) levels for differentiating the control group from the PRLC groups is shown in Figure 3 (high levels of biomarkers in the PRLC group) and Figure 4 (low levels of biomarkers in the PRLC group).